Quality & Documentation Each GHK-Cu batch released by Vertex Labs is supported by batch-level documentation and Certificate of Analysis availability following quality review
BPC-157 administration attenuated gastric lesions, reduced esophagitis severity, strengthened anastomotic integrity, and markedly increased pressure at both the anastomotic site and pyloric sphincter
Cell cycle analysis For cell cycle analysis, cells were harvested and fixed in 80% ethanol overnight at 20 C, washed with PBS, and then stained with PI and 100 g/ml RNaseA
Generative AI statement The author(s) declare that no Generative AI was used in the creation of this manuscript
A compounding pharmacy prepares BPC-157 for a specific patient with a doctors prescription for therapeutic use
BPC-157 Oral Capsules 30 Capsules Gastric-Resistant Capsule Form Description BPC-157 Oral Capsules offer the extensively studied Body Protection Compound-157 peptide in a convenient gastric-resistant capsule format designed specifically for oral route bioavailability research